Article Details

Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock - TradingView

Retrieved on: 2025-06-30 14:30:22

Tags for this article:

Click the tags to see associated articles and topics

Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock - TradingView. View article details on hiswai:

Excerpt

Bio-Techne Corp. TECH has recently entered into a distribution agreement with the U.S. Pharmacopeia (“USP”) to sell USP monoclonal antibody (mAb) ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo